114 related articles for article (PubMed ID: 37211848)
1. HSP90-regulated CHIP/TRIM21/p21 Axis Involves in the Senescence of Osteosarcoma Cells.
Xu GS; Lin YN; Zeng Q; Li ZP; Xiao T; Ye YS; Li ZY; Gao X
Protein Pept Lett; 2023; 30(6):513-519. PubMed ID: 37211848
[TBL] [Abstract][Full Text] [Related]
2. PRMT5-TRIM21 interaction regulates the senescence of osteosarcoma cells by targeting the TXNIP/p21 axis.
Li YH; Tong KL; Lu JL; Lin JB; Li ZY; Sang Y; Ghodbane A; Gao XJ; Tam MS; Hu CD; Zhang HT; Zha ZG
Aging (Albany NY); 2020 Feb; 12(3):2507-2529. PubMed ID: 32023548
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of Runx2 by HSP90 controls osteosarcoma apoptosis via the AKT/GSK-3β/β-catenin signaling.
Liang GH; Liu N; He MT; Yang J; Liang ZJ; Gao XJ; Rahhal AH; He QY; Zhang HT; Zha ZG
J Cell Biochem; 2018 Jan; 119(1):948-959. PubMed ID: 28681940
[TBL] [Abstract][Full Text] [Related]
4. TRIM21-regulated Annexin A2 plasma membrane trafficking facilitates osteosarcoma cell differentiation through the TFEB-mediated autophagy.
Zhang HT; Zeng Q; Wu B; Lu J; Tong KL; Lin J; Liu QY; Xu L; Yang J; Liu X; Liu W; Zhang YF; Lian Q; Liu L; Gao X
Cell Death Dis; 2021 Jan; 12(1):21. PubMed ID: 33414451
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation.
Krishnamoorthy GP; Guida T; Alfano L; Avilla E; Santoro M; Carlomagno F; Melillo RM
J Biol Chem; 2013 Jun; 288(24):17481-94. PubMed ID: 23629654
[TBL] [Abstract][Full Text] [Related]
6. YWHAZ Binds to TRIM21 but Is Not Involved in TRIM21-stimulated Osteosarcoma Cell Proliferation.
Zeng QZ; Liu WT; Lu JL; Liu XH; Zhang YF; Liu LX; Gao XJ
Biomed Environ Sci; 2018 Mar; 31(3):186-196. PubMed ID: 29673441
[TBL] [Abstract][Full Text] [Related]
7. Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.
Shu X; Liu H; Zhen R; Jie Y; Chen L; Qi H; Wang C; Wang R; Chen D; Ran Y
Oncol Rep; 2020 Jul; 44(1):313-324. PubMed ID: 32377704
[TBL] [Abstract][Full Text] [Related]
8. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
[TBL] [Abstract][Full Text] [Related]
9. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615
[TBL] [Abstract][Full Text] [Related]
10. The HSP90 inhibitor 17-AAG synergizes with doxorubicin and U0126 in anaplastic large cell lymphoma irrespective of ALK expression.
Georgakis GV; Li Y; Rassidakis GZ; Medeiros LJ; Younes A
Exp Hematol; 2006 Dec; 34(12):1670-9. PubMed ID: 17157164
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression.
Schulz R; Marchenko ND; Holembowski L; Fingerle-Rowson G; Pesic M; Zender L; Dobbelstein M; Moll UM
J Exp Med; 2012 Feb; 209(2):275-89. PubMed ID: 22271573
[TBL] [Abstract][Full Text] [Related]
12. TRIM21 overexpression promotes tumor progression by regulating cell proliferation, cell migration and cell senescence in human glioma.
Zhao Z; Wang Y; Yun D; Huang Q; Meng D; Li Q; Zhang P; Wang C; Chen H; Lu D
Am J Cancer Res; 2020; 10(1):114-130. PubMed ID: 32064156
[TBL] [Abstract][Full Text] [Related]
13. The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma.
Hu Y; Bobb D; He J; Hill DA; Dome JS
Cancer Biol Ther; 2015; 16(6):949-57. PubMed ID: 25920748
[TBL] [Abstract][Full Text] [Related]
14. miR-485-5p/HSP90 axis blocks Akt1 phosphorylation to suppress osteosarcoma cell proliferation and migration via PI3K/AKT pathway.
Liu Q; Wang Z; Zhou X; Tang M; Tan W; Sun T; Wang Y; Deng Y
J Physiol Biochem; 2020 May; 76(2):279-290. PubMed ID: 32100243
[TBL] [Abstract][Full Text] [Related]
15. AQP2 Abundance is Regulated by the E3-Ligase CHIP Via HSP70.
Centrone M; Ranieri M; Di Mise A; Berlingerio SP; Russo A; Deen PMT; Staub O; Valenti G; Tamma G
Cell Physiol Biochem; 2017; 44(2):515-531. PubMed ID: 29145196
[TBL] [Abstract][Full Text] [Related]
16. Cks1 proteasomal degradation is induced by inhibiting Hsp90-mediated chaperoning in cancer cells.
Khattar V; Fried J; Xu B; Thottassery JV
Cancer Chemother Pharmacol; 2015 Feb; 75(2):411-20. PubMed ID: 25544127
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Xeroderma Pigmentosum Complementation Group C Expression by 17-Allylamino-17-Demethoxygeldanamycin Enhances Bevacizumab-Induced Cytotoxicity in Human Lung Cancer Cells.
Chen JC; Ko JC; Taso YC; Cheng HH; Chen TY; Yen TC; Lin YW
Pharmacology; 2021; 106(3-4):154-168. PubMed ID: 33202406
[TBL] [Abstract][Full Text] [Related]
18. ErbB2 degradation mediated by the co-chaperone protein CHIP.
Zhou P; Fernandes N; Dodge IL; Reddi AL; Rao N; Safran H; DiPetrillo TA; Wazer DE; Band V; Band H
J Biol Chem; 2003 Apr; 278(16):13829-37. PubMed ID: 12574167
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane potentiates the efficacy of 17-allylamino 17-demethoxygeldanamycin against pancreatic cancer through enhanced abrogation of Hsp90 chaperone function.
Li Y; Zhang T; Schwartz SJ; Sun D
Nutr Cancer; 2011; 63(7):1151-9. PubMed ID: 21875325
[TBL] [Abstract][Full Text] [Related]
20. Acquired resistance to HSP90 inhibitor 17-AAG and increased metastatic potential are associated with MUC1 expression in colon carcinoma cells.
Liu X; Ban LL; Luo G; Li ZY; Li YF; Zhou YC; Wang XC; Jin CG; Ye JG; Ma DD; Xie Q; Huang YG
Anticancer Drugs; 2016 Jun; 27(5):417-26. PubMed ID: 26872308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]